C12N 5/0656
Adult fibroblasts
Official title: {Adult fibroblasts}
C12N5/0656 (Adult fibroblasts) appears on 300 US grants and 760 published applications in this corpus.
Search patents in C12N- Granted patents
- 300
- Published applications
- 760
- Assignees
- 434
- Inventors
- 1,499
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1977 | 1 | 0 |
| 1978 | 0 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 1 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 3 | 0 |
| 1999 | 3 | 0 |
| 2000 | 5 | 0 |
| 2001 | 2 | 0 |
| 2002 | 5 | 19 |
| 2003 | 4 | 14 |
| 2004 | 10 | 7 |
| 2005 | 3 | 10 |
| 2006 | 8 | 9 |
| 2007 | 2 | 10 |
| 2008 | 3 | 9 |
| 2009 | 0 | 15 |
| 2010 | 3 | 17 |
| 2011 | 3 | 9 |
| 2012 | 6 | 12 |
| 2013 | 9 | 20 |
| 2014 | 5 | 22 |
| 2015 | 12 | 23 |
| 2016 | 17 | 20 |
| 2017 | 10 | 35 |
| 2018 | 17 | 42 |
| 2019 | 16 | 68 |
| 2020 | 22 | 45 |
| 2021 | 19 | 59 |
| 2022 | 21 | 69 |
| 2023 | 23 | 60 |
| 2024 | 20 | 57 |
| 2025 | 31 | 64 |
| 2026 | 16 | 45 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Meat flavouring6 Oct 2026US 12,751,473 B2Ants Innovate Pte. Ltd.
- Therapeutic use of fibroblasts for use in wound healing1 Sep 2026US 12,721,866 B2Fibrobiologics, Inc.
- Treatment of disc degenerative disease and stimulation of proteoglycan synthesis by fibroblast conditioned media and formulations thereof25 Aug 2026US 12,716,055 B2Fibrobiologics, Inc.
- Compositions and methods for increasing the culture density of a cellular biomass within a cultivation infrastructure18 Aug 2026US 12,709,738 B2The Upside Group Inc.
- Hydrogels4 Aug 2026US 12,698,472 B2Leibniz-Institut für Neue Materialien gemeinnützige GmbH
- Extracellular vesicles8 Oct 2026US 2026/0308526 A1VivaZome Therapeutics Pty Ltd
- Methods for generating artificial thymus, products and uses thereof17 Sep 2026US 2026/0275290 A1
- Compositions and methods for preservation of isolated mitochondria17 Sep 2026US 2026/0275294 A1The Sallie A. Burdine Breast Foundation
- Microenvironment-simulated cell culture system and microenvironment-simulated cell culturing method3 Sep 2026US 2026/0258336 A1Fluidiconic Biotechnology Co., Ltd.
- Use of engineered materials to locally induce differentiation of engineered cells20 Aug 2026US 2026/0242725 A1
Most cited
By later US patents
- Implantable biocompatable immunoisolatory vehicle for delivery of selected therapeutic products448US 6,083,523 ABrown University · 2000
- Methods of making conditioned cell culture medium compositions249US 6,372,494 B1Advanced Tissue Sciences, Inc. · 2002
- Multilayer skin or dermal equivalent having a layer containing mesenchymal stem cells232US 6,497,875 B1Case Western Reserve University · 2002
- Delivery of therapeutic biologicals from implantable tissue matrices159US 6,692,738 B2The General Hospital Corporation · 2004
- Transplants for myocardial scars141US 6,099,832 AGenzyme Corporation · 2000